Dear Colleagues and Friends,
It gives me great pleasure to welcome you all to the 9th Annual Scientific Congress of China Interventional Therapeutics (CIT) 2011 in partnership with TCT to be held at the China National Convention Center (CNCC), Beijing, from Wednesday, March 16th through Saturday, March 19th, 2011. The Congress is organized by Chinese Medical Association, CIT Board of Directors, Chinese Society of Cardiology, and Cardiovascular Research Foundation / Transcatheter Cardiovascular Therapeutics (TCT), and co-sponsored by PCR and ESC Working Group on Cardiovascular Surgery, Complex Cardiovascular Therapeutics (CCT), Sociedad Latinoamericana de Cardiología Intervencionista (SOLACI), Angioplasty Summit - TCTAP, Cardiovascular Research Technologies (CRT), Asian Interventional Cardiovascular Therapeutics (AICT), New Cardiovascular Horizons (NCVH), Division of Medicine and Health, Chinese Academy of Engineering, Cardiovascular Society of Cross-Straits Medicine Exchange Association, China Cardiovascular Promotive Association, Hong Kong College of Cardiology, and Chinese Medical Journal.
It is our great honor and privilege that CIT will be in partnership with TCT from 2011, by which CIT will be more closely connecting to TCT and getting stronger support from the most prestigious education and scientific exchange program. CIT 2011 in partnership with TCT will offer more than 900 didactic presentations, 500 abstracts, and 40 live cases in four-day program. The opening of CIT and the exclusive plenary session will take place in the morning of March 17th, and the late breaking trials will be in the afternoon. PCR and ESC Working Group on Cardiovascular Surgery, CCT, SOLACI, Angioplasty Summit, CRT, AICT, and NCVH will organize more productively joint programs at CIT 2011. The four major areas of interventional cardiology: coronary, structural heart disease, endovascular, and heart rhythm will be featured by comprehensive scientific sessions, which are designed to provide information and resources that can be immediately translated into improved patient care. Original research is presented in the forms of oral and electronic abstracts, late-breaking trials and first report investigations, topic-oriented symposia, workshops, and concurrent sessions. The basic and advanced interventional techniques, interventional pharmacology, cardiovascular prevention, and cardiovascular imaging are also covered in-depth.
As the largest interventional cardiology meeting and one of the most educational teaching courses in Asia Pacific region, it is estimated that more than 5,000 experts, cardiologists, radiologists, vascular medicine specialists, industrial partners and other health care professionals with a special interest in the field of interventional cardiology will attend the meeting. Participants will have the opportunities to share scientific information and the latest advances, to exchange expertise in interventional cardiology, to renew our friendship, and to increase worldwide collaboration. The Congress will also provide a unique opportunity for the industries to exhibit their new products and to contact with the cardiologists more closely.
The meeting venue of CIT 2011 is still the CNCC, China's largest and the most modern international conference center with primary location and completed facilities. It is located in the heart of Beijing Olympic Green, standing right next to the Bird Nest (China National Stadium), Water Cube (National Aquatic Center) and National Indoor Stadium. Beijing is a highly civilized and ancient city rich in historical sites and full of cultural events. The city is also an international metropolis with modern and efficient tourist systems. I cordially invite you to come to see the new China after the World EXPO 2010, Shanghai, and enjoy the traditional Chinese hospitality.
I look forward to welcoming you to CIT 2011.
Run-Lin Gao, MD, FACC, FSCAI
Professor of Medicine
Chairman, China Interventional Therapeutics (CIT)